KuCoin EU Files MiCAR Application in Austria to Ensure Compliant EEA Operations
Key Takeaways: KuCoin EU Exchange GmbH ("KuCoin EU") is applying for a…
VCTI Launches BEAD Application Service to Help Broadband Providers Secure Funding Faster with Higher Business Case Accuracy
BEAD Resource Center Launches on VCTI Website SOMERSET, N.J., Feb. 5, 2025…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
Adam Ferrari Health Science Scholarship Application Window Closes
January 10, 2025 10:30 ET | Source: The Ferrari Foundation DENVER, Jan.…
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
Back to media releasesNext media release LONDON, Jan. 7, 2025 /PRNewswire/ --…
Alaskas Department of Revenue Forms Strategic Partnership with Saige Consulting to Overhaul the Permanent Fund Dividend Application System
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The State of Alaska,…
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
November 27, 2024 16:10 ET | Source: Applied Therapeutics NEW YORK, Nov.…
Anocca Announces Submission of Clinical Trial Application for Multi-asset Trial VIDAR-1 in Advanced Pancreatic Cancer
November 26, 2024 03:00 ET | Source: Anocca AB Application to the…